SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-20-000020
Filing Date
2020-08-06
Accepted
2020-08-06 16:14:42
Documents
16
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blcm-20200806.htm   iXBRL 8-K 49072
2 EX-99.1 a2020q2exh991earningsr.htm EX-99.1 165161
8 BELLICUM LOGO image1.jpg GRAPHIC 34612
  Complete submission text file 0001358403-20-000020.txt   414969

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20200806.xsd EX-101.SCH 2423
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20200806_cal.xml EX-101.CAL 710
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20200806_def.xml EX-101.DEF 1643
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20200806_lab.xml EX-101.LAB 24030
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20200806_pre.xml EX-101.PRE 12661
9 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20200806_htm.xml XML 10711
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 201081803
SIC: 2834 Pharmaceutical Preparations